ABOUT AUTHOR
Dr. Saurabh Kumar Banerjee
Associate Professor
School of Pharmaceutical Management
The IIHMR University,
Jaipur (Pin-302029), Rajasthan, INDIA
Email: saurabh@iihmr.edu.in
Mob: - +91-8890398067
The whole world is facing a catastrophic situation which it has never faced before due to outbreak of COVID-19. As per the Coronavirus disease 2019 (COVID-19) Situation Report – 74, by WHO Globally 972 303 confirmed cases and 50,322 deaths have been reported as on April 3, 2020. No region of the world which includes Western Pacific Region (1,08,930) confirmed cases and 3760 deaths), European region (5,41,808 confirmed cases and 37 103 deaths), South-East Asia region (5881 confirmed cases and 245 deaths) , Eastern Mediterranean region (62 236 confirmed cases and 3439 deaths) , regions of America ( 247 473 confirmed cases and 5600 deaths) and African region ( 5263 confirmed cases and 164 deaths), has been spared by the brutality of the deadly virus (Coronavirus disease 2019 (COVID-19) Situation Report – 74, by WHO). The total confirmed cases in India are reported to be 1965 with total deaths reaching out to be 62 as per the Coronavirus disease 2019 (COVID-19) Situation Report – 74, by WHO as on April 3, 2020.
source https://www.pharmatutor.org/articles/the-corona-pandemic-a-silver-lining-for-the-pharma-molecular-diagnostic-industry
No comments:
Post a Comment